Espa?ol
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Surgery is the main treatment for most ovarian cancers. The extent of surgery depends on how far the cancer has spread and your overall health. For women of childbearing age with certain kinds of tumors that are found at the earliest stage, it may be possible to treat the cancer without removing both ovaries and the uterus.
For epithelial ovarian cancer, surgery has 2 main goals: staging and debulking. If your cancer isn’t properly staged and debulked, you may need to have more surgery later, so it’s important that this surgery is done by a gynecologic oncologist who’s trained and experienced in ovarian cancer surgery.
The first goal of ovarian cancer surgery is to stage the cancer to see how far the cancer has spread from the ovary. Staging is very important because ovarian cancers at different stages are treated differently. If the staging isn't done correctly, the doctor may not be able to decide on the best treatment.
Usually staging ovarian cancer involves removing:
Other biopsy samples might also be taken to help in staging:
The other important goal of ovarian cancer surgery is debulking – removing as much of the tumor as possible. Debulking is very important when ovarian cancer has already spread throughout the abdomen (belly) at the time of surgery.
People whose tumors have been optimally debulked have a better outlook (prognosis) than those left with larger tumors after surgery.
In some cases, other organs might be affected by debulking:
After ovarian cancer surgery, most women will stay in the hospital for 3 to 7 days and can resume their usual activities within 4 to 6 weeks.
To help find and remove ovarian cancer, surgeons may use a special imaging system for intraoperative imaging:
Common side effects from pafolacianine (Cytalux) include belly pain, heartburn, itching, chest pain, nausea, vomiting, and flushing.
Your doctor may ask you to avoid supplements with folic acid for a few days before surgery, because these can interfere with the imaging.
For germ cell tumors and stromal tumors, the main goal of surgery is to remove the cancer.
Most ovarian germ cell tumors are treated with a hysterectomy and bilateral salpingo-oophorectomy. If the cancer is in only one ovary and you still want to be able to have children, only the ovary containing the cancer and the fallopian tube on the same side are removed (leaving behind the other ovary and fallopian tube and the uterus).
Ovarian stromal tumors are often confined to just one ovary, so surgery may just remove that ovary. If the cancer has spread, more tissue may need to be removed. This could mean a hysterectomy and bilateral salpingo-oophorectomy, and even debulking surgery.
Sometimes, after child bearing is finished, surgery to remove the other ovary, the other fallopian tube, and the uterus may be recommended, for both germ cell and stromal ovarian tumors.
For more general information about surgery as a treatment for cancer, see Cancer Surgery.
To learn about some of the side effects listed here and how to manage them, see Managing Cancer-related Side Effects.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Cannistra SA, Gershenson DM, Recht A. Ch 76 - Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.
Morgan M, Boyd J, Drapkin R, Seiden MV. Ch 89 – Cancers Arising in the Ovary. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier; 2014: 1592.
National Comprehensive Cancer Network (NCCN)--Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer. V2.2025. Accessed May 20, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
Last Revised: August 8, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
Help us end cancer as we know it, for everyone.